![Michael Bolinder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Michael Bolinder worked at Mallinckrodt Pharmaceuticals Ltd. from 2013 to 2015 as Head-Marketing & Commercial Strategy.
From 2015 to 2022, Mr. Bolinder was at Acacia Pharma Group Ltd., serving as Chief Executive Officer from 2019 to 2022.
Mr. Bolinder completed undergraduate education at Florida State University.
Eerdere bekende functies van Michael Bolinder
| Bedrijven | Functie | Einde |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Algemeen Directeur | 01-06-2022 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkoop & Marketing | 01-08-2015 |
Opleiding van Michael Bolinder
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kies MarketScreener 
